person

Vasileios K.

Country
Greece
Department
Intensive Care Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
11
Sites with multiple studies

Has run more than one trial at 11 of 29 partner sites.

Specializations

Infectious Disease Management

The investigator specializes in treating severe systemic infections, with particular emphasis on candidemia and its complications. Their research explores innovative therapeutic approaches for managing invasive fungal infections.

  • Systemic Candida Infections
  • Antifungal Therapy
  • Combination Treatment Approaches

Their work includes evaluation of adjunctive treatments to enhance standard therapeutic protocols for fungal bloodstream infections.

Critical Care Medicine

The investigator focuses on advanced treatments for sepsis, particularly investigating novel immunotherapeutic approaches. Their expertise extends to identifying and treating specific sepsis endotypes, especially those driven by interferon-gamma.

  • Sepsis Endotype Classification
  • Immunological Biomarkers
  • Targeted Biological Therapies

Their research encompasses the development of personalized treatment strategies for severe inflammatory conditions in critical care settings.

Immunotherapy Research

The investigator specializes in the application of monoclonal antibody therapies for severe infections and inflammatory conditions. Their work includes investigating immune response modulation in critical illness.

  • Cytokine-Targeted Therapies
  • Immune Response Modulation
  • Treatment Optimization Protocols

Their expertise extends to developing precise dosing strategies for immunological interventions in severe systemic conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.